The clinical value of the EpCAM biomarker and its association with immune cell infiltration in bladder cancer
This study highlights the prognostic value of EpCAM in bladder cancer, revealing a strong link between EpCAM expression and disease pathogenesis. These results underscore the need for further research to validate these findings and explore the significance of EpCAM as a therapeutic target in managing bladder cancer.
Authors
- Taoufik Nedjadi (ORCID: https://orcid.org/0000-0003-4986-7118)
- Jaudah Al‐Maghrabi (ORCID: https://orcid.org/0000-0002-0812-9592)
- Hifzur Rahman Ansari (ORCID: https://orcid.org/0000-0002-0646-1743)
- Mohamed Eldigire Ahmed (ORCID: https://orcid.org/0000-0003-0326-7926)
- Sihem Aouabdi (ORCID: https://orcid.org/0000-0002-6231-2515)
- Alaa Samkari (ORCID: https://orcid.org/0000-0003-4342-763X)
Institutions
- King Abdulaziz University (SA)
- King Saud bin Abdulaziz University for Health Sciences (SA)
- King Abdullah International Medical Research Center (SA)
Publication Details
- Journal
- Diagnostic Pathology
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1186/s13000-025-01696-1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King Abdullah International Medical Research Center